Results 81 to 90 of about 1,578,947 (161)

BOLD-100 in Combination with FOLFOX Is a Broadly Effective Therapeutic Strategy for Gastric Cancer. [PDF]

Int J Mol Sci
Skubleny D, Rajput F, Wickware J, Venkat B, Spratlin J, Schiller DE, Rayat GR.   +6 more
europepmc   +1 more source

A case of folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy regimen associated neurotoxicity and review of literature. [PDF]

BMC Neurol
Srivastava J, DO EK, Sivakumar S, Mullaguri N.   +3 more
europepmc   +1 more source

Administration of Nivolumab Plus FOLFOX Therapy to a Patient with Gastric Cancer Undergoing Hemodialysis. [PDF]

Intern Med
Yoshida T, Kodama N, Matsumoto T, Taguchi D, Shimazu K, Fukuda K, Shibata H.   +6 more
europepmc   +1 more source

Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review. [PDF]

Front Immunol
Jin Y, Fu L, Zhao Y, Tong Z, Tan Y.
europepmc   +1 more source

Novel Cytotoxic Pt(IV) Compounds with Improved Safety Profiles. [PDF]

Int J Mol Sci
Antonets AA, Voroshilkina KM, Shutkov IA, Mazur DM, Serkova TP, Shevtsova EF, Yakovlev DS, Pshenichnikova MS, Ibragimova UM, Litvinov RA, Spasov AA, Milaeva ER, Nazarov AA.   +12 more
europepmc   +1 more source

BREAKWATER Phase III: results for encorafenib and cetuximab plus mFOLFOX6 in first-line <i>BRAF</i> V600E-mutant metastatic colorectal cancer. [PDF]

Future Oncol
Kopetz S, Tabernero J, Élez E.
europepmc   +1 more source

Comparative Effectiveness of Oral Fluoropyrimidines Versus FOLFOX as Adjuvant Therapy for Stage III Colon Cancer: A Retrospective Cohort Study Using Overlap-Weighted Restricted Mean Survival Time Analysis. [PDF]

Pharmacoepidemiol Drug Saf
Huang SF, Hsu CW, Wu CC, Chen YH.
europepmc   +1 more source

Phase I clinical trial of lobaplatin combined with image-guided volume-modulated arc radiation therapy in locally advanced cervical cancer. [PDF]

BMC Cancer
You J, Wu D, Tie J, Shen J, Yuan Y, Gu X, Wang W, Li X.   +7 more
europepmc   +1 more source

A next-generation multimetal complex induces immunogenic cell death with distinct transcriptomic signatures.

Chem Commun (Camb)
Babu T, Levine MS, Zeng B, Sessler JL.
europepmc   +1 more source

HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. [PDF]

Signal Transduct Target Ther
Li SH, Zuo ZJ, Lu LH, Xu LZ, Wang QX, Zhao RC, Mei J, Li JB, Zheng L, Guo RP, Wei W.   +10 more
europepmc   +1 more source